| Patricia Marie Baller, CNM | |
|
1470 E Valentine Circle Nw, Canton, OH 44708-3155 | |
| (330) 452-6060 | |
| (330) 452-6065 |
| Full Name | Patricia Marie Baller |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 1470 E Valentine Circle Nw, Canton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932142635 | NPI | - | NPPES |
| 2211985 | Medicaid | OH | |
| 000000186740 | Other | OH | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | NM-011104 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Marie Baller, CNM 1470 E Valentine Circle Nw, Canton, OH 44708-3155 Ph: (330) 452-6060 | Patricia Marie Baller, CNM 1470 E Valentine Circle Nw, Canton, OH 44708-3155 Ph: (330) 452-6060 |
News Archive
Graphene and its nano-sized little sibling, nanographene, are well known for their remarkable photoelectronic properties. However, biomedical applications are hampered by the insolubility of the materials, especially in water.
Kaiser Health News staff writer Jenny Gold, working in collaboration with NPR, reports: "As of mid-January, most of NYU is up and running again, including the labor and delivery unit. But the question still looms whether NYU will lose some of the patients and even doctors who sought refuge at NYU's biggest competitors after the storm. If that happens, the storm could end up having a long term impact on NYU's valuable share of the fiercely competitive health care market in New York City."
Foresight Corporation's Chief Technology Officer Ed Hafner testified Thursday, December 10, before the National Committee on Vital and Health Statistics (NCVHS) Subcommittee on Standards, providing insights and recommendations to help the industry prepare for the upcoming transition to the ASC X12 5010 transaction standard and ICD-10 code sets, as mandated by HIPAA.
Some industry officials say the automatic renewal of some health law insurance plans could have a negative impact on the financial aid that consumers receive. Meanwhile, narrow networks continue to be the subject of backlash.
Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.
› Verified 6 days ago